CGEN
Price
$1.65
Change
-$0.03 (-1.79%)
Updated
Nov 13 closing price
Capitalization
158.19M
97 days until earnings call
Intraday BUY SELL Signals
MLTX
Price
$12.56
Change
-$0.21 (-1.64%)
Updated
Nov 13 closing price
Capitalization
889.84M
104 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CGEN vs MLTX

Header iconCGEN vs MLTX Comparison
Open Charts CGEN vs MLTXBanner chart's image
Compugen
Price$1.65
Change-$0.03 (-1.79%)
Volume$195.95K
Capitalization158.19M
MoonLake Immunotherapeutics
Price$12.56
Change-$0.21 (-1.64%)
Volume$2.38M
Capitalization889.84M
CGEN vs MLTX Comparison Chart in %
CGEN
Daily Signal:
Gain/Loss:
MLTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CGEN vs. MLTX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEN is a Hold and MLTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (CGEN: $1.68 vs. MLTX: $12.77)
Brand notoriety: CGEN and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEN: 68% vs. MLTX: 53%
Market capitalization -- CGEN: $158.19M vs. MLTX: $889.84M
CGEN [@Biotechnology] is valued at $158.19M. MLTX’s [@Biotechnology] market capitalization is $889.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEN’s FA Score shows that 1 FA rating(s) are green whileMLTX’s FA Score has 1 green FA rating(s).

  • CGEN’s FA Score: 1 green, 4 red.
  • MLTX’s FA Score: 1 green, 4 red.
According to our system of comparison, CGEN is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEN’s TA Score shows that 4 TA indicator(s) are bullish while MLTX’s TA Score has 4 bullish TA indicator(s).

  • CGEN’s TA Score: 4 bullish, 5 bearish.
  • MLTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than CGEN.

Price Growth

CGEN (@Biotechnology) experienced а +2.44% price change this week, while MLTX (@Biotechnology) price change was +20.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

CGEN is expected to report earnings on Feb 19, 2026.

MLTX is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($890M) has a higher market cap than CGEN($158M). CGEN YTD gains are higher at: 9.804 vs. MLTX (-76.417). CGEN has higher annual earnings (EBITDA): -19.81M vs. MLTX (-196.98M). MLTX has more cash in the bank: 425M vs. CGEN (93.9M). CGEN has less debt than MLTX: CGEN (2.97M) vs MLTX (75.8M). CGEN has higher revenues than MLTX: CGEN (22.1M) vs MLTX (0).
CGENMLTXCGEN / MLTX
Capitalization158M890M18%
EBITDA-19.81M-196.98M10%
Gain YTD9.804-76.417-13%
P/E Ratio64.00N/A-
Revenue22.1M0-
Total Cash93.9M425M22%
Total Debt2.97M75.8M4%
FUNDAMENTALS RATINGS
CGEN: Fundamental Ratings
CGEN
OUTLOOK RATING
1..100
1
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
19
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGENMLTX
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
56%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
69%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
68%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 28 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
75%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CGEN
Daily Signal:
Gain/Loss:
MLTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VEOEY16.930.01
+0.06%
Veolia Environnement
PTZIF11.33N/A
N/A
PATRIZIA SE
TTLTF0.17N/A
N/A
Total Telcom, Inc.
PREKF19.24-0.16
-0.82%
Prairiesky Royalty Ltd.
BRGC0.18-0.01
-4.71%
BrightRock Gold Corp.

CGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEN has been loosely correlated with NURPF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEN jumps, then NURPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEN
1D Price
Change %
CGEN100%
-2.33%
NURPF - CGEN
46%
Loosely correlated
N/A
ASPHF - CGEN
41%
Loosely correlated
N/A
BDTX - CGEN
41%
Loosely correlated
+5.41%
ORMP - CGEN
40%
Loosely correlated
+2.07%
MLTX - CGEN
37%
Loosely correlated
+8.68%
More

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been closely correlated with KALA. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if MLTX jumps, then KALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+8.68%
KALA - MLTX
88%
Closely correlated
-2.55%
IOBT - MLTX
75%
Closely correlated
-6.00%
NEVPF - MLTX
70%
Closely correlated
N/A
XNCR - MLTX
50%
Loosely correlated
-3.23%
NUVL - MLTX
48%
Loosely correlated
+0.91%
More